Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment.
Zettl I, Ivanova T, Zghaebi M, Rutovskaya MV, Ellinger I, Goryainova O, Kollárová J, Villazala-Merino S, Lupinek C, Weichwald C, Drescher A, Eckl-Dorna J, Tillib SV, Flicker S.
Zettl I, et al. Among authors: rutovskaya mv.
Front Immunol. 2022 Nov 9;13:1022418. doi: 10.3389/fimmu.2022.1022418. eCollection 2022.
Front Immunol. 2022.
PMID: 36439110
Free PMC article.